Information for Physicians
Questions about this year's conference? Call (802) 656-2292.
- Please register for the conference by 8:00 am on October 3, 2014. Walk-ins are welcome after the registration deadline. However, space is limited and some sessions may be closed. Register early!
- The conference will be held at the Sheraton Burlington Hotel & Conference Center in South Burlington, Vermont.
- The conference opens at 8:00 am with over 60 exhibits in the Exhibit Hall.
- Sessions begin at 9:00 am and end at 4:05 pm.
- The sessions and exhibits are free due to the generous support of the Susan G. Komen for the Cure Vermont-New Hampshire Affiliate, BlueCross BlueShield of Vermont, Front Porch Forum, and Seventh Generation.
This year’s Breast Cancer Conference features a Physician Track of education sessions specifically geared toward primary care providers and other health care professionals. In addition to the Physician Track of talks, a variety of other conference sessions are approved for continuing medical education.
The University of Vermont College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Vermont designates this educational activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
Credit approval is also pending for Social Worker Credit and Nutrition and Dietetics CPE Credit. Application will be made for ASRT credit approval.
Cost of AMA Category 1 Credits™ and AAFP prescribed credit hours — $40.
Cost of all other healthcare provider credit (up to 5.5 credit) — $20.
Sessions that have been designated for physician credit are as follows:
1-2: PHYSICIAN TRACK: Breast Cancer and Bone: Novel Biomarkers and Treatments / Jane Lian, PhD and Marie Wood, MD / This session will explore the biology behind cancer metastases to bone. Additionally, we will look at what factors influence the spread of cancer to bone and what providers can do to help prevent and treat bone metastais. This session is specifically geared toward primary care providers and other health care professionals.
1-3: Kinesio Tape Management of Trunk, Breast, and Arm Lymphedema / Julia Child, PT, CLT-LANA / This session will discuss the benefits of kinesio tape in the management of chronic and acute lymphedema. Lymphedema causes a decrease in the space between skin and muscle, resulting in constriction of lymphatic flow and pressure on sensory receptors which can cause pain and numbness. Kinesio tape applied to skin can improve lymphatic flow, resulting in a decrease in edema and discomfort associated with lymphedema.
1-4: Predictors of Recurrence After a DCIS Diagnosis / Brian Sprague, PhD / This session will discuss the basic biology of DCIS (ductal carcinoma in situ, the most common type of non-invasive breast cancer) and the magnitude of this diagnosis as a public health problem; the typical disease-free survival rates for DCIS, including the average time from diagnosis to an invasive breast cancer diagnosis; and predictors of disease-free survival, including factors related to the patient, her treatments, and the characteristics of the DCIS diagnosis.
1-6: Adjuvant Therapy / Paul Unger, MD / This talk will cover the basic concept of giving treatments in addition to surgery for breast cancer patients. It will discuss the role of chemotherapy, hormonal, and immunological treatments for early stage breast cancer.
1-7: Integration of Palliative Care into Cancer Care / Janet Ely, MSN, AOCNP, FNP and Mary Giancola, MSW, LICSW / Palliative care is specialized medical care for people with serious illness focused on improving quality of life through relief from the symptoms, pain and stress of a serious illness. Care is provided by a team of caregivers who wholly support and care for the patient and family. Integrating palliative care into cancer care is appropriate for any cancer diagnosis and provides an extra layer of support from the time of initial diagnosis, through active treatment and, when needed, helping patients and families transition to end of life care.
1-9 Changing Paradigms of Cancer Treatment: Can Peripheral Blood be a Surrogate for Tumor Biopsy to Identify Treatment Targets in Patients with Advanced Breast Cancer? / Mary Chamberlin, MD / Tumor biopsy can be an invasive process, but it is often deemed necessary to identify treatment for advanced breast cancer patients. But is there another way? This session will explore the use of peripheral blood as an alternative way to identify new treatment targets .
1-10: Lymph Node Transplant: A Case Study / Justine Dee, PT, MS, OCS / A lymph node transplant involves moving lymph nodes from one area of the body to another in order to help patients affected by lymphedema. This session will present the case of a patient with breast cancer related lymphedema who underwent this procedure.
2-2: PHYSICIAN TRACK: The Continuum of Oncology Rehabilitation for Cancer Survivors / Kim Dittus, MD, PhD / Cancer survivors often have specific needs when it comes to recovery and rehabilitation. We will discuss the unique rehabilitative needs of these survivors and how providers can help facilitate the road to recovery. This session is specifically geared toward primary care providers and other health care professionals.
2-4: Breast Cancer and Weight Gain / Jean Harvey, PhD, RD / Weight gain is common in breast cancer patients after diagnosis. Unfortunately, survivors who are overweight are more likely to have their cancer recur than trimmer survivors. This workshop reviews why weight is likely to change during treatment and details activities you can do that have consistently been shown to reduce your risk of breast cancer, improve your odds of survival if you are diagnosed, and help prevent other illnesses.
2-7: Ovarian Cancer Screening and Prevention / Elise Everett, MD / This session will discuss the various methods used to screen for ovarian cancer, symptoms of the disease, and prophylactic removal of the ovaries for women at high risk for disease.
2-9: Integrative Therapies in Cancer Care: Expert Panel Discussion / Philip Trabulsy, MD and Janet Kahn, PhD, LMT / A lively presentation and discussion will be presented by a panel of experts in the field regarding the growing body of evidence surrounding the clinical value of supportive cancer care using the best evidence-informed therapies from the field of Complementary and Integrative Medicine. The evidence continues to grow with regards to the use of Integrative therapies for symptom management, pain management, rehabilitation, survivorship, health promotion and cancer prevention. The clinical panel of integrative practitioners will discuss their particular healing disciplines approach to support the cancer patient. This will include such topics as integrative nutrition, natural supplements, herbal treatments, acupuncture, oncologic massage therapy, and mind-body medicine.
3-1: Screening: When, How Often, and Why? / Tracy Dolan, Sally Herschorn, MD, Benjamin Littenberg, MD, Donal Weaver, MD, and Marie Wood, MD / Screening guidelines change from state to state and from person to person, but what does that mean for you? This panel will discuss the multiple screening guidelines out there, explain why recommendations differ, and help you figure out how to make the choice that is best for you.
3-2: PHYSICIAN TRACK: Cancer and Venous Thrombosis: Risk Factors, Treatment, and Prevention / Neil Zakai, MD / Venous thrombosis is a common complication of malignancy which affects both the quality and the quantity of life. It is important to understand the risk factors for cancer-associated thrombosis, the appropriate treatment, and novel prevention strategies in order to provide the highest quality care. In this session, we will discuss the risk factors and treatments for cancer-associated thrombosis and novel prevention strategies. This session is specifically geared toward primary care providers and other health care professionals.
3-7: Ovarian Cancer Treatments / Elise Everett, MD / This session will discuss the treatments used to treat ovarian cancer at various stages, side effect management, and research for new therapies. An overview of surgical and medical interventions used.
3-9: Evaluating Safety and Efficacy of Novel Drug Therapies: The Journey from Early Testing to FDA Approval / Bernard Cole, PhD / This presentation will provide an overview of the process that new drugs must go through before they may be approved by the Food and Drug Administration. We will discuss early- and intermediate-phase clinical testing, where emphasis is typically focused on dosing, safety and preliminary evaluation of efficacy. We will then introduce the randomized clinical trial and its importance in modern medicine. The presentation will include a summary of the studies and process leading to the recent FDA approval of pertuzumab for two indications in breast cancer.
KEYNOTE PRESENTATION: Looking for Avoidable Causes of Breast Cancer: No Trivial Pursuit! / Tom Ahern, PhD, MPH / The premise of cause and effect drives epidemiologists, scientists that deal with incidence, distribution, and possible control of diseases, in their hunt for avoidable causes of breast cancer. In this talk, Dr. Ahern will explain a theory which focuses current research efforts to find highly prevalent, yet avoidable, contributors in the development of breast cancer which, if mitigated, substantially reduce the burden of breast cancer in a population.
L-2 PHYSICIAN TRACK: Cardiac Disease and Breast Cancer / Susan G. Lakoski, MD / Treatment for breast cancer may have increased risk factors for heart disease, and care providers need to understand these risk factors and integrate them into the standard risk factors such as obesity, lipid profile, smoking, DM, and inactivity. This talk is geared for the care provider that needs to screen breast cancer survivors for heart disease. Testing guidelines, symptom management and interventions will be discussed. This session is specifically geared toward primary care providers and other healthcare professionals.
4-1: Chemobrain / Owen Drudge, PhD, Julie Dumas, PhD, Moira Mulligan, MS, CCC-SLP, and Patricia O’Brien, MD / Women frequently comment that their memory declines during and after therapy for breast cancer. A panel of experts, including a cognitive expert, an oncologist, and a breast cancer survivor, discuss the science behind cognitive change and research efforts to increase our understanding of this condition.
4-2: PHYSICIAN TRACK: Deep Inferior Epigastric Artery Perforator (DIEP) Flap Breast Reconstruction / Robert Nesbit, MD / The DIEP flap is a common breast reconstruction procedure that has many benefits. This session will examine DIEP flap breast reconstruction as well as the benefits and challenges for physicians and their patients. This session is specifically geared toward primary care providers and other health care professionals.
4-3: Phthalates are Everywhere – But Do They Cause Breast Cancer? / Tom Ahern, PhD, MPH / Phthalate compounds have made their way into a number of consumer products including food containers, children's toys, cosmetics, and pharmaceuticals. Phthalates are suspected to disrupt hormonal pathways in our bodies, and have the potential to cause cancer. Dr. Thomas Ahern will discuss the pervasiveness of these compounds in our daily environment, summarize current evidence of the effect of phthalates on breast cancer occurrence, and introduce his new study, funded by Susan G. Komen for the Cure, which will thoroughly explore this topic in a population of women at risk for breast cancer.
4-5: A Multidisciplinary Approach to Breast Cancer Diagnosis and Treatment / Kim Dittus, MD, PhD, Maureen Harmon, MD, Deborah Rubin, MD, Mary Stanley, MD, and Erin Tsai, MD / Current breast cancer care involves the coordination of multiple medical disciplines: surgery, pathology, radiology, and specialists in chemotherapy and radiation treatment. In this session you will sit in on a reenactment of a weekly breast cancer case conference where specialists review clinical, radiologic, and pathologic findings of patients recently diagnosed with breast cancer and discuss the best approaches to treatment.
4.8: Marijuana for Symptom Relief / Bridget Conry, Shayne Lynn, Jeffrey Wallin, and Lindsey Wells / What is my role as a provider? How do I become a registered patient? This session will focus on the process of registering with the Vermont Marijuana Registry and what happens after a patient is registered.
5-1: Are There Choices in Fertility Management after Breast Cancer? / Elizabeth McGee, MD / What are the options for fertility and family building after one has been treated for breast cancer? How can you know if you are still fertile? Can infertility be treated? Is it safe? Could it be an option for me? This session will answer these and other important questions about fertility management after breast cancer.
5-2: PHYSICIAN TRACK: The Many Benefits of Palliative Care as a Part of a Comprehensive Cancer Team / Jaina Clough, MD / Palliative care is an essential piece of treatment that many providers need to know more about. This session will discuss palliative treatments from a provider's standpoint and give a comprehensive discussion on how every provider can benefit from knowing more about this field. This session is specifically geared toward primary care providers and other health care professionals. Please note that in order to fill the palliative care portion of the new CME requirements, this session will run until 3:15 pm.
5-5: Clinical Trials and You / Chris Holmes, MD, PhD / Clinical trials are among the greatest weapons we have in fighting cancer. This panel discussion will explore the world of clinical trials, how they help find new treatments for cancer, and how you can become a part of this important process.
5-6: Aromatase Inhibitors: Managing Pain, Hot Flashes, and Bone and Sexual Health / Joanna Schwartz, PharmD / This session will focus on emerging data and treatments for aromatase inhibitor-induced muscle and joint pains, vaginal dryness and pain with intercourse, and bone health. Dr Schwartz, who is a pharmacist, will also provide information on access to the treatments in the studies, such as if they are over-the-counter, prescription only, or compounding pharmacy only.
5-8: What’s New in Breast Cancer Reconstruction? / Robert Nesbit, MD / In this session, we will focus on newer techniques for reconstruction after breast cancer surgery. Some of the techniques discussed may include oncoplastic surgery after lumpectomy, nipple sparing mastectomy, and new technologies that may improve reconstructive outcomes.
6-1: Oncology Rehabilitation – Steps to Wellness / Kim Dittus, MD, PhD, Kristie Grover, PhD, Rebecca Reynolds, BS, Diane Stevens, PT / Steps to Wellness is a comprehensive Oncology Rehab program, the program will be presented by the team that provides this care. It is also a research Program and Dr. Dittus will be discussing the findings of this research, the implications will be discussed. Persons interested in joining the program will fine the overview helpful, and professionals who want to build a team in their facility will learn gain an understanding of the team development. Fitness is very important, how a structured exercise program can improve health after cancer treatment will be presented.
6-2: PHYSICIAN TRACK: The Use of Opiates During Cancer Treatment / Mark Pasanen, MD / The use of opiates as a way to treat cancer symptoms and relieve pain can be extremely beneficial to patients, but it also carries risks if misused. This session will discuss the prescribing of opiates, when it is best to do so, and how to properly manage these powerful tools. Please note that in order to fill the opiate management portion of the new CME requirements, this session will run until 4:15 pm.
6-3: Risk of Breast Cancer Recurrence Associated with Carbohydrate Intake and Tissue Expression of IGF-1 Receptor / Jennifer Emond, MSc, PhD / There is growing interest in how carbohydrate content of the diet may impact prognosis among breast cancer survivors. The study presented in this session assessed the association between a change in carbohydrate intake within a few years of completing treatment on prognosis among postmenopausal breast cancer survivors, and tested the mediating effect of that association due to expression of the insulin-like growth factor 1 (IGF1) receptor in the primary breast tumor tissue.
6-4: What’s New in Radiation Oncology / Rick Lovett, MD / This session discusses the principles of radiation and how tissue sparing is accomplished, the new advances in radiation treatments, and how individualized radiation treatments are designed.
6-5: Symptom Control During Chemotherapy / Jennifer May, RD, CD / This session will provide helpful hints for the management of common side effects of chemotherapy, including taste changes, nausea, and constipation. The goal of the presentation will be to help patients find strategies for optimal tolerance of treatment and preservation of quality of life. Additionally, focus will be placed on the maintenance of one’s nutritional status to ensure treatment can be continued uninterrupted, and aid in healing. Information will be presented through the collaboration of a dietitian and a panel of oncology nurses. Time will be allotted for questions and discussion.
6-7 Breast Lymphedema / Kristi Johnson, PT, LANA / This session will cover the myths and mysteries of lymphedema specifically related to breast edema. Learning objectives are to obtain a basic understanding of: the lymphatic system, breast related lymphedema, risks and precautions, as well as some treatment options.
6-8: Is There Sex After Cancer? Reviving your Sex Life After Cancer / Gale Golden, LICSW, BCD / When an illness occurs, the accompanying treatments, medications and surgeries may diminish desire for sex and intimacy. Even in the best of relationships, an open discussion about sex may be daunting and thus avoided. This discussion will offer practical help on starting the dialogue and reviving the comfort of an intimate and sexual relationship. Help is on its way!
Last modified September 19 2014 11:33 AM